Quest Diagnostics, a diagnostic information services provider, agreed to acquire LifeLabs, a community laboratory tests provider, from OMERS, an investment company, for $985m. "Quest has supported laboratories, hospitals and academic centres in Canada with specialized testing services for over two decades, including during the COVID-19 pandemic. This transaction is predicated on our strong belief that we can help LifeLabs accelerate growth and improve healthcare. We are committed to working with the LifeLabs team to ensure service continuity and enhance access and innovation to meet the needs of Canada's growing and aging population," Jim Davis, Quest Diagnostics Chairman, CEO and President.